|Videos|July 15, 2021
Incorporating Esketamine into Practice for Treatment-Resistant Depression
Advertisement
Episodes in this series
Requirements that healthcare clinics must satisfy to become a certified treatment center permitted to administer intranasal esketamine to patients with treatment-resistant depression.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Okie Tokie Talk: Adolescent Cannabis Use in Oklahoma, the Sooner State
2
The Concept of Mental Illness, and Why the DSM Approach Is Wrong
3
Data Presentation on XPro1595 for Alzheimer Disease With Inflammation at CTAD
4
Delay on Cobenfy Alzheimer Disease Psychosis Data Following Phase 3 Study “Irregularities,” New Patients Enrolled
5
